Analytical chemistry
Cure8 research brief
Why This Matters
A colon-targeted, enzyme-activated imaging probe could help distinguish early versus late inflammatory stages in IBD and provide a noninvasive fecal fluorescence signal—potentially improving disease monitoring beyond current clinical tools.
Who Should Pay Attention
Researchers studying IBD biomarkers and imaging; clinicians interested in new diagnostic/monitoring technologies; translational scientists working on molecular probes.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
Researchers describe a granzyme A (GzmA)–activatable near-infrared nanoprobe (IR780 NP) that becomes fluorescent when cleaved by GzmA and is formulated with an enteric coating (Eudragit S100) to release in the colon.
In mouse models of dextran sulfate sodium (DSS)–induced colitis, the probe produced stronger colon fluorescence at an early disease stage (day 4) with higher GzmA expression and lower fluorescence at a later stage (day 8). The authors also report that the probe enabled fecal fluorescence readout as a noninvasive adjunct to imaging.
The study is preclinical (mouse models) and presented as an analytical/chemical research article with an abstract-level description. It demonstrates a proof-of-concept molecular imaging agent targeting a protease associated with inflammation, not a tested clinical diagnostic yet.
If this work advances, it could offer a way to noninvasively monitor colitis stage through colon-targeted fluorescence imaging and fecal fluorescence, but safety, efficacy, and translation to humans remain to be established.
Keep In Mind
This report is an abstract/experimental preclinical study in DSS mouse models; it does not report human data. Translation to clinical use requires additional safety testing, validation in human tissues, regulatory review, and demonstration that the signal adds actionable information beyond established tests. Summary confidence: medium.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationAnalytical chemistry
AuthorsXinru Kong, Junya Zhang, Qiaochu Jiang +3 more
InstitutionState Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing211189, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedSep 23, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Oral renal-clearable gold supraclusters for near-infrared II urinary diagnosis of ulcerative colitis.
The study describes a new urine-based fluorescent biosensor that detected inflamed intestinal sites and tracked treatment response earlier and more sensitively than fecal calprotectin in a mouse model of IBD, which could...
Clinical utility of magnetic resonance enterography for pediatric Crohn’s disease: a review with illustrative cases and a focus on Japan
MRE is a key radiation-free imaging tool for children with Crohn’s disease; this review summarizes its clinical utility and how it fits with other pediatric-focused diagnostic approaches in Japan.
Monitoring Crohn's Disease After Surgery with Fecal Calprotectin - Physician's Weekly
People with Crohn's disease who have an ileostomy need reliable, noninvasive tools to monitor for postoperative small-bowel inflammation. This study suggests fecal calprotectin measured from ileostomy output may help...